Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Ciccolini

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Biomedical Chromatography : BMC|August 19, 2007
Validation of a simple HPLC method for assay of haplamine and its metabolites in plasma suitable for pharmacokinetic application in ratsSompheary Ea, Claude Aubert, Sarah Giacometti, et al.
Scientific Reports|November 5, 2016
In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical ModelingSéverine Mollard, Raphaelle Fanciullino, Sarah Giacometti, et al.
Cancer Drug Resistance (Alhambra, Calif.)|March 21, 2024
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer modelGuillaume Sicard, Dorian Protzenko, Sarah Giacometti, et al.
Plos One|February 7, 2009
Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progressionSophie Belin, Ferdinand Kaya, Ghislaine Duisit, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 27, 2023
Killing a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patientsSophie Marolleau, Alice Mogenet, Clara Boeri, et al.
Anti-Cancer Drugs|August 24, 2006
Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridineJean-Louis Fischel, Joseph Ciccolini, Patricia Formento, et al.
Pediatric Blood & Cancer|March 6, 2010
Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?Emilie Moreau, Nicolas André, Carole Coze, et al.
Current Topics in Medicinal Chemistry|September 18, 2012
100% human monoclonal antibodies in oncology: hype or breakthrough?Stephan Benay, Raphaelle Fanciullino, Cedric Mercier, et al.
Anti-Cancer Drugs|June 3, 2005
Effect of several compounds on biliary excretion of paclitaxel and its metabolites in guinea-pigsSok-Siya Bun, Sarah Giacometti, Raphaëlle Fanciullino, et al.
Vaccines|November 4, 2020
Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic PerspectiveFélicien Le Louedec, Fanny Leenhardt, Clémence Marin, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Biomedical Chromatography : BMC|August 19, 2007
Validation of a simple HPLC method for assay of haplamine and its metabolites in plasma suitable for pharmacokinetic application in ratsSompheary Ea, Claude Aubert, Sarah Giacometti, et al.
Scientific Reports|November 5, 2016
In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical ModelingSéverine Mollard, Raphaelle Fanciullino, Sarah Giacometti, et al.
Cancer Drug Resistance (Alhambra, Calif.)|March 21, 2024
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer modelGuillaume Sicard, Dorian Protzenko, Sarah Giacometti, et al.
Plos One|February 7, 2009
Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progressionSophie Belin, Ferdinand Kaya, Ghislaine Duisit, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 27, 2023
Killing a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patientsSophie Marolleau, Alice Mogenet, Clara Boeri, et al.
Anti-Cancer Drugs|August 24, 2006
Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridineJean-Louis Fischel, Joseph Ciccolini, Patricia Formento, et al.
Pediatric Blood & Cancer|March 6, 2010
Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?Emilie Moreau, Nicolas André, Carole Coze, et al.
Current Topics in Medicinal Chemistry|September 18, 2012
100% human monoclonal antibodies in oncology: hype or breakthrough?Stephan Benay, Raphaelle Fanciullino, Cedric Mercier, et al.
Anti-Cancer Drugs|June 3, 2005
Effect of several compounds on biliary excretion of paclitaxel and its metabolites in guinea-pigsSok-Siya Bun, Sarah Giacometti, Raphaëlle Fanciullino, et al.
Vaccines|November 4, 2020
Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic PerspectiveFélicien Le Louedec, Fanny Leenhardt, Clémence Marin, et al.
Pageof 17